(Login BolsaPT & Canal Forex) |
|
 Sepracor Inc. - [Ticker: SEPR] |     | | Última Trade | | Range 52 Semanas | [0,000 - 0,000] | | Hora da Última Trade | N/A - N/A | Price-Target 1 Ano | N/A | | Variação | () | Capitalização Bolsista | 3 | | Bid / Ask | N/A | EPS | 0,00 | | Abertura | | PER | 12,69% | | Máximo | | Pagamento Dividendo | N/A | | Mínimo | | Data Ex-Dividendo | N/A | | Fecho Anterior | 0,000 | Yield | N/A | | Volume | | Volume Médio (3m) | 0 | | Nota: Os dados podem apresentar atraso de alguns minutos. |
| | Ver cotações de outros activos |
| Últimos 10 Tópicos no Fórum sobre Sepracor Inc.: | | Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc.. |
|
Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)
| |
Board ChangeLondon South East (registration) (blog)He has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals, Inc.), Accenture plc and GlaxoWellcome plc (now GlaxoSmithKline plc). ?Trevor trained as a microbiologist at University of Reading, obtaining a PhD in ... |
|
Desloratadine Market Analysis and In-Depth Analysis on Market Dynamics, Emerging Trends, Growth Factors and ...MilTechDesloratadine Market Key Players Analysis: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...e mais » |
|
Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...PR Newswire (press release)Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...e mais » |
|
Sunovion Pharmaceuticals Inc. Announces Company Name ChangeBusiness Wire (press release)BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...e mais » |
|
Sunovion Celebrates Five-Year Anniversary MilestoneBusiness Wire (press release)MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...e mais » |
Boston Globe |
Sunovion gets OK for its epilepsy drugBoston GlobeMarlborough biotech Sunovion Pharmaceuticals Inc. is preparing to start selling a new antiseizure pill early next year, following Food and Drug Administration approval of the medication. FDA regulators signed off on Sunovion's first epilepsy drug ...e mais » |
Reuters |
Dainippon to buy US drug firm Sepracor for $2.6 billionReutersBOSTON/TOKYO Dainippon Sumitomo Pharma Co Ltd agreed on Thursday to buy U.S. drugmaker Sepracor Inc for $2.6 billion, giving the Japanese firm a big, local sales force in the world's largest drugs market. The deal is the latest in a string of overseas ... |
| Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. |
|
![Gráfico de Sepracor Inc. - [Ticker: SEPR]](http://www.bolsapt.com/grafico/bolsapt-SEPR-5-dias.png "Gráfico 5 Dias de Sepracor Inc. [SEPR] BolsaPT")
